• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.15% Nasdaq Up 0.36%

    More On CADX

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    Financials

    • Income Statement
    • Balance Sheet
    • Cash Flow

    Cadence Pharmaceuticals Inc. (CADX)

    -NasdaqGS
    13.98 0.00(0.00%) Mar 18, 4:00PM EDT
    Add to Portfolio
    Prev Close:13.98
    Open:N/A
    Bid:N/A
    Ask:N/A
    1y Target Est:11.00
    Beta:1.43
    Next Earnings Date:N/A
    Day's Range:N/A - N/A
    52wk Range:4.74 - 14.24
    Volume:0
    Avg Vol (3m):3,077,490
    Market Cap:N/A
    P/E (ttm):N/A
    EPS (ttm):-0.28
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CADX

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :N/A
    Quarterly EPS Est (Mar-14) :N/A
    Mean Recommendation*:1.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Cadence Pharmaceuticals, Inc., a biopharmaceutical company, focuses on acquiring, in-licensing, developing, and commercializing proprietary products principally for use in the hospital setting. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback